Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation

Cytomegalovirus infection (CMV) is an extremely serious problem in patients after hematopoietic stem cells transplantation (HSCT). We have evaluated importance of major risk factors CMV development in patients after allogeneic HSCT (n = 168) from related (n = 56), unrelated (n = 90) or haploidentica...

Full description

Bibliographic Details
Main Authors:	D. N. Balashov, P. E. Trakhtman, E. V. Skorobogatova, Yu. V. Skvortsova, I. P. Schipitsyna, A. A. Maschan
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Subjects:	cytomegalovirus hematopoietic stem cells transplantation risk factors preventive treatment
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/759

Similar Items

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Monitoring of resistanceassociated mutations in UL97 gene of cytomegalovirus in children after allogeneic hematopoietic stem cell transplantation
by: Kozhushnaya O.S., et al.
Published: (2022-03-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
by: Yongsheng Ruan, et al.
Published: (2022-10-01)

Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients
by: Jhong-Lin Wu, et al.
Published: (2017-06-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Endothelial injury syndromes after hematopoietic stem cell transplantation: analyzing clinical case
by: Y. V. Skvortsova, et al.
Published: (2022-11-01)

Cytomegalovirus infection in transplant recipients
by: Luiz Sergio Azevedo, et al.
Published: (2015-07-01)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
by: Johnny Zakhour, et al.
Published: (2022-12-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
by: Hsin - Chen Lin, et al.
Published: (2017-05-01)

Detection of Cytomegalovirus in Post Hematopoietic Stem Cells Transplant Recipients by Real-Time PCR
by: Saifullah Khan Niazi, et al.
Published: (2023-10-01)

Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan
by: Chao-Neng Cheng, et al.
Published: (2022-04-01)

Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature
by: Donglin Yang, et al.
Published: (2023-12-01)

Risk factors and survival of refractory cytomegalovirus reactivation after allogeneic peripheral blood stem cell transplantation
by: Ziwen Duan, et al.
Published: (2022-12-01)

Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation
by: Jintao Xia, et al.
Published: (2022-08-01)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
by: M. A. Maschan, et al.
Published: (2014-07-01)

Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
by: M. A. Maschan, et al.
Published: (2014-07-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Quantification of CD8+CD38+ T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
by: Vânia Abadia Soares Lino, et al.
Published: (2011-01-01)

Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis
by: Martyna Wlodarczyk, et al.
Published: (2024-03-01)

Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
by: Tsung-Jang Yeh, et al.
Published: (2022-04-01)

Mutations in the <i>UL97</i> gene of cytomegalovirus (<i>Herpesvirales: Herpesviridae: Cytomegalovirus: Human betaherpesvirus</i> 5) associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cells
by: M. V. Demin, et al.
Published: (2022-03-01)

Late cytomegalovirus infection after hematopoietic stem cell transplantation: case reports
by: Samara Grapiuna Pinheiro, et al.
Published: (2013-01-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study
by: Yuling Zhang, et al.
Published: (2024-01-01)

Infections in Hematopoietic Stem Cell Transplant Recipients and Prevention
by: Ayşegül YEŞİLKAYA, et al.
Published: (2006-06-01)

A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation
by: Qixiang Ye, et al.
Published: (2018-05-01)

Pre-Transplant Platelet Refractoriness and Alternative Donors Are Associated With Cytomegalovirus Retinitis in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia
by: Yuehong Zhang, et al.
Published: (2022-03-01)

The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01)